KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
D&H Peps: 27 Kovera certificates.
The lab's record shows 27 certificates printed for D&H Peps, analysed between 22 Mar 2026 and 28 May 2026, covering 23 products. Median HPLC purity is 99.80%. Kovera graded 27 as a pass and 0 as a fail.
27
certificates
99.80%
median purity
23
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 27 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 11 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
23 AS PRINTEDTirzepatide · 3Retatrutide · 2Semax · 25-Amino-1MQ · 1BAC Water (Standard) · 1BPC-157 · 1Cagrilintide · 1CJC-1295 no DAC · 1Epithalon · 1GHK-Cu · 1Glow · 1IGF-1 LR3 · 1Ipamorelin · 1Kisspeptin-10 · 1Klow · 1KPV · 1Melanotan-2 · 1MOTS-c · 1NAD+ · 1Selank · 1SS-31 · 1Thymosin alpha-1 · 1VIP · 1
Every certificate
NEWEST FIRST · 27 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-F65CF9 | Retatrutide | RT10526A | 99.512% | 113.4%11.34 of 10 mg | 28 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-CB2EAD | Epithalon | EP50526A | 99.309% | 105.7%52.84 of 50 mg | 28 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-A332F5 | 5-Amino-1MQ | AM5526A | 99.396% | 114.8%5.74 of 5 mg | 28 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-992750 | Melanotan-2 | MT210526A | 99.081% | 112.4%11.24 of 10 mg | 28 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-609958 | Ipamorelin | IPA5526A | 99.797% | 109.2%5.46 of 5 mg | 28 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4F3DF7 | Kisspeptin-10 | KSP5526A | 99.621% | 118.8%5.94 of 5 mg | 28 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-49BF7D | CJC-1295 no DAC | CJND5526A | 99.139% | 110.2%5.51 of 5 mg | 28 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-3BEB63 | Tirzepatide | TZ60526A | 98.976% | 109.7%65.82 of 60 mg | 28 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-3191BD | Klow | KW80526A | 99.593% | 110.3%88.28 of 80 mg | 28 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-25D5B9 | Semax | SM10426A | 99.426% | 98.4%9.84 of 10 mg | 28 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-155056 | Thymosin alpha-1 | THA50526A | 99.147% | 108.6%5.43 of 5 mg | 28 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-088DF9 | KPV | KPV10526A | 99.201% | 109.1%10.91 of 10 mg | 28 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0859CD | IGF-1 LR3 | IGF1526A | 98.863% | 108.0%1.08 of 1 mg | 28 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-9EEBE2 | BAC Water (Standard) | BW3326A | 99.932% | 357.0%10.71 of 3 mg | 20 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-A50AF0 | SS-31 | Ss10426A | 99.917% | 98.3%9.83 of 10 mg | 6 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-7EF3A7 | Semax | SM5426A | 99.926% | 114.4%5.72 of 5 mg | 6 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-79B50C | Tirzepatide | TZ40426A | 99.948% | 107.5%43.01 of 40 mg | 6 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-57BF84 | NAD+ | ND100426A | 99.938% | 106.3%106.32 of 100 mg | 6 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-4DF136 | Cagrilintide | CG5426A | 99.866% | 108.6%5.43 of 5 mg | 6 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0DB07F | Selank | SL10426A | 99.806% | 108.1%10.81 of 10 mg | 6 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-FB6DF6 | MOTS-c | MC10326A | 99.923% | 116.1%11.61 of 10 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-94055A | Retatrutide | RT10326A | 99.928% | 109.6%10.96 of 10 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-8C176C | Tirzepatide | TZ20326A | 99.941% | 112.9%22.58 of 20 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-86A870 | BPC-157 | BP10326A | 99.967% | 105.2%10.52 of 10 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-5613BA | VIP | VP10326A | 99.924% | 107.4%10.74 of 10 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-379A1B | Glow | GW70326A | 99.734% | 106.0%74.18 of 70 mg | 22 Mar 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-253BD8 | GHK-Cu | GH50326A | 99.951% | 113.8%56.91 of 50 mg | 22 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |